Aura Announces Exercise of the Underwriters’ Option to Purchase Additional Shares

How will the exercise of the underwriters’ option affect the total shares outstanding and EPS? Are there any lock‑up or secondary offering restrictions that could affect future liquidity? What is the size of the share increase relative to the current float and recent trading volume? What is the likely impact on the company’s capital structure and debt‑to‑equity ratio? Will the increased share count affect institutional ownership limits or trigger any fund rebalancing? Will the market perception of the underwriters’ confidence impact short‑term demand for the stock? Will the additional shares put upward pressure on the stock price due to potential dilution? How does this capital raise compare to Aura’s previous financing activities? How might this transaction influence Aura’s valuation multiples compared to peers in the sector? What are the intended uses of the proceeds from the additional share purchase?